With regard to the adaptive immune system, its modulation and re-activation by targeting PD-1 or PD-L1 showed promising clinical results in various cancer types including lung cancer8,10, which also accounted for most of MPE cases in the present study (56.1%) and in literature1. Here, CD274 is linked to cancer.